An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion
2018 · Journal of Clinical Investigation · 359 citations
https://doi.org/10.1172/jci123360
A
Amy V. Paschall
Emory University(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
98
Papers
2.0K
Citations
22
h-index
29
i10-index
Amy V. Paschall is an academic researcher from Emory University. The author has contributed to research in topics: Immune cells in cancer & Cancer Immunotherapy and Biomarkers & Ferroptosis and cancer prognosis. The author has an h-index of 22, co-authored 84 publications.
ORCID: 0000-0001-9144-7534Papers by this author
worksThe NF-κB p65 and p50 homodimer cooperate with IRF8 to activate iNOS transcription
2015 · BMC Cancer · 61 citations
https://doi.org/10.1186/s12885-015-1808-6
Glycopeptide epitope facilitates HIV-1 envelope specific humoral immune responses by eliciting T cell help
2020 · Nature Communications · 25 citations
https://doi.org/10.1038/s41467-020-16319-0
CD301b lectin expression in the breast tumor microenvironment augments tumor growth
2025 · Research Square · 0 citations
https://doi.org/10.21203/rs.3.rs-8148605/v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat